- Home
- DATS vs EVGN Comparison
DATS vs EVGN Comparison
Compare DATS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DATS
- EVGN
- Stock Information
- Founded
- DATS 2014
- EVGN 1999
- Country
- DATS United States
- EVGN Israel
- Employees
- DATS N/A
- EVGN N/A
- Industry
- DATS Computer Software: Prepackaged Software
- EVGN Agricultural Chemicals
- Sector
- DATS Technology
- EVGN Industrials
- Exchange
- DATS Nasdaq
- EVGN Nasdaq
- Market Cap
- DATS 13.4M
- EVGN 11.4M
- IPO Year
- DATS 2021
- EVGN N/A
- Fundamental
- Price
- DATS $2.66
- EVGN $1.21
- Analyst Decision
- DATS
- EVGN Strong Buy
- Analyst Count
- DATS 0
- EVGN 1
- Target Price
- DATS N/A
- EVGN $3.50
- AVG Volume (30 Days)
- DATS 88.3K
- EVGN 90.5K
- Earning Date
- DATS 08-22-2025
- EVGN 08-19-2025
- Dividend Yield
- DATS N/A
- EVGN N/A
- EPS Growth
- DATS N/A
- EVGN N/A
- EPS
- DATS N/A
- EVGN N/A
- Revenue
- DATS $388.00
- EVGN $6,765,000.00
- Revenue This Year
- DATS N/A
- EVGN N/A
- Revenue Next Year
- DATS N/A
- EVGN $113.18
- P/E Ratio
- DATS N/A
- EVGN N/A
- Revenue Growth
- DATS N/A
- EVGN N/A
- 52 Week Low
- DATS $1.11
- EVGN $0.95
- 52 Week High
- DATS $9.34
- EVGN $4.29
- Technical
- Relative Strength Index (RSI)
- DATS 55.66
- EVGN 45.00
- Support Level
- DATS $2.25
- EVGN $1.18
- Resistance Level
- DATS $2.46
- EVGN $1.36
- Average True Range (ATR)
- DATS 0.14
- EVGN 0.07
- MACD
- DATS 0.01
- EVGN -0.00
- Stochastic Oscillator
- DATS 87.00
- EVGN 34.78
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.